Who owns Vor Biopharma Inc. (VOR)? Elite investor 13F holders
4 tracked elite investors reported holding Vor Biopharma Inc as of 2026-06-30, including Caligan Partners, Renaissance Technologies LLC, D.E. Shaw, Sarissa Capital. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Caligan Partners | VOR BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 35440465.00 USD | 1925066.000000 | Shares | hold | Original filing |
| Tudor Investment | VOR BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Renaissance Technologies LLC | VOR BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 607733.00 USD | 33011.000000 | Shares | reduce | Original filing |
| D.E. Shaw | VOR BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1006493.00 USD | 54671.000000 | Shares | buy | Original filing |
| Irenic Capital | VOR BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Sarissa Capital | VOR BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 467596.00 USD | 25399.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.